rs779524035
Positions:
Variant summary
Our verdict is Benign. Variant got -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2
The NM_002294.3(LAMP2):c.264A>T(p.Ile88=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000579 in 1,208,129 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 2 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.000045 ( 0 hom., 2 hem., cov: 20)
Exomes 𝑓: 0.0000018 ( 0 hom. 0 hem. )
Consequence
LAMP2
NM_002294.3 synonymous
NM_002294.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.166
Genes affected
LAMP2 (HGNC:6501): (lysosomal associated membrane protein 2) The protein encoded by this gene is a member of a family of membrane glycoproteins. This glycoprotein provides selectins with carbohydrate ligands. It may play a role in tumor cell metastasis. It may also function in the protection, maintenance, and adhesion of the lysosome. Alternative splicing of this gene results in multiple transcript variants encoding distinct proteins. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -17 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.76).
BP6
Variant X-120455490-T-A is Benign according to our data. Variant chrX-120455490-T-A is described in ClinVar as [Likely_benign]. Clinvar id is 415502.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.166 with no splicing effect.
BS2
High Hemizygotes in GnomAd4 at 2 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
LAMP2 | NM_002294.3 | c.264A>T | p.Ile88= | synonymous_variant | 3/9 | ENST00000200639.9 | |
LAMP2 | NM_001122606.1 | c.264A>T | p.Ile88= | synonymous_variant | 3/9 | ||
LAMP2 | NM_013995.2 | c.264A>T | p.Ile88= | synonymous_variant | 3/9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
LAMP2 | ENST00000200639.9 | c.264A>T | p.Ile88= | synonymous_variant | 3/9 | 1 | NM_002294.3 | P3 | |
LAMP2 | ENST00000434600.6 | c.264A>T | p.Ile88= | synonymous_variant | 3/9 | 1 | A1 | ||
LAMP2 | ENST00000371335.4 | c.264A>T | p.Ile88= | synonymous_variant | 3/9 | 1 | A1 | ||
LAMP2 | ENST00000706600.1 | c.264A>T | p.Ile88= | synonymous_variant | 3/9 |
Frequencies
GnomAD3 genomes AF: 0.0000449 AC: 5AN: 111250Hom.: 0 Cov.: 20 AF XY: 0.0000598 AC XY: 2AN XY: 33438
GnomAD3 genomes
AF:
AC:
5
AN:
111250
Hom.:
Cov.:
20
AF XY:
AC XY:
2
AN XY:
33438
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00000545 AC: 1AN: 183476Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 67916
GnomAD3 exomes
AF:
AC:
1
AN:
183476
Hom.:
AF XY:
AC XY:
0
AN XY:
67916
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000182 AC: 2AN: 1096879Hom.: 0 Cov.: 30 AF XY: 0.00 AC XY: 0AN XY: 362261
GnomAD4 exome
AF:
AC:
2
AN:
1096879
Hom.:
Cov.:
30
AF XY:
AC XY:
0
AN XY:
362261
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000449 AC: 5AN: 111250Hom.: 0 Cov.: 20 AF XY: 0.0000598 AC XY: 2AN XY: 33438
GnomAD4 genome
AF:
AC:
5
AN:
111250
Hom.:
Cov.:
20
AF XY:
AC XY:
2
AN XY:
33438
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Danon disease Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 24, 2016 | - - |
Cardiovascular phenotype Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 11, 2021 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at